| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3281851 | Clinical Gastroenterology and Hepatology | 2015 | 33 Pages |
Abstract
Based on a controlled trial, pinaverium reduces symptoms of IBS. It can be considered a first-line treatment for IBS. Trial registration: NCT01641224 (www.ClinicalTrials.gov).
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Liang Zheng, Yaoliang Lai, Weimin Lu, Baiwen Li, Heng Fan, Zhixiang Yan, Changzhen Gong, Xinjian Wan, Jing Wu, Dawei Huang, Yuanyuan Wang, Yumei Mei, Zhen Li, Zhengyan Jiang, Xingxing Liu, Jingyi Ye, Yongqiang Yang, Huisuo Huang, Jun Xiao,